Rokshin Tablet (Roxithromycin)

Adult dose

Adults: Administer 150 mg (potency) of roxithromycin orally twice a day, in the morning and evening before meals (take). For pneumonia, administer 300 mg (potency) once a day before breakfast. Adjust the dose as appropriate according to age and symptoms.

This medication can rarely cause serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and acute generalized exanthematous pustulosis. If symptoms such as blistering of the skin or damage to mucous membranes occur, discontinue use immediately. Patients who are allergic to this medication or to macrolide antibiotics, or who are taking certain medications (terfenadine, astemizole, cisapride, pimozide, ergot alkaloids, mizolastine), should not use this medication. Caution is advised when using in patients with poor liver function, elderly patients, or in combination with other specific antibiotics, as well as in patients with a risk of cardiac arrhythmias. This medication can very rarely trigger serious allergic reactions such as anaphylactic shock; if any abnormal symptoms occur, stop administration immediately and seek medical attention. Abnormal reactions may occur in various systems including the liver, blood, digestive system, nervous system, and skin; consult a healthcare professional if symptoms arise. Prolonged use of this medication may lead to resistance, so it is important to use it only for the necessary duration and to administer it appropriately based on susceptibility testing. Patients with decreased liver function should undergo regular testing, while those with poor kidney function do not require separate dosage adjustments. Doses and duration should be strictly observed in children, and overdose should be avoided. This medication may interact with other drugs, causing heart issues or toxic symptoms when combined with specific medications; patients must inform their healthcare provider of all medications they are taking. Women who are pregnant or breastfeeding should only use this medication after consulting with their physician and it is recommended to discontinue breastfeeding during treatment. Elderly patients do not require dosage adjustments but should be closely monitored for their physical condition. Dizziness or visual disturbances may occur; caution is needed when operating machinery or driving. Finally, this medication should be kept out of reach of children, and it is safe to avoid transferring it to other containers.

Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, shock, fever, rash, allergic skin reaction, angioedema, eosinophilia, agranulocytosis, leukopenia, thrombocytopenia, cholestatic acute hepatitis, hepatocellular acute hepatitis, jaundice, elevated AST, elevated ALT, elevated ALP, increased serum bilirubin, loss of appetite, nausea, vomiting, upper abdominal discomfort, abdominal pain, abdominal distension, diarrhea, colitis, loose stools, hemorrhagic colitis, pancreatitis, bronchospasm, cough, dyspnea, abnormal chest X-ray, interstitial pneumonia, drowsiness, headache, dizziness, tongue numbness, paralysis, dysgeusia, ageusia, olfactory disturbance, loss of smell, erythema multiforme, purpura, superinfection with resistant pathogens, transient hearing loss, hearing impairment, visual disturbances, blurred vision, conjunctival hyperemia, general malaise, weakness, palpitations, QT prolongation, ventricular tachycardia, arthralgia, nosebleeds, menstrual abnormalities, inflammation of oral and vaginal mucosa, hallucinations, confusion

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle, 1000 tablets/bottle